News
4h
Health and Me on MSNRight Before Approval, FDA Again Scrutinizes Novavax Covid-19 VaccineNovavax is working with the FDA to meet additional requirements and hopes to secure full approval as soon as possible.
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...
Scientists have uncovered why vaccines can elicit a stronger immune response if they are administered in the same arm.
New research from Murdoch University's Australian National Phenome Center confirms that multiple doses of COVID-19 vaccines ...
When it comes to getting the most out of a vaccine, arm consistency can make a difference. Some studies suggest that getting ...
17h
Zacks Investment Research on MSNCountdown to Moderna (MRNA) Q1 Earnings: A Look at Estimates Beyond Revenue and EPSWall Street analysts expect Moderna (MRNA) to post quarterly loss of $2.92 per share in its upcoming report, which indicates a year-over-year increase of 4.9%. Revenues are expected to be $126.98 ...
HealthDay News — On Tuesday, the US Department of Health and Human Services announced that the government will invest $176 million in Moderna to expedite the creation of a pandemic influenza vaccine, ...
Under emergency use, vaccines can be removed even after a health emergency is considered to be over. Full approval from the FDA means a product can stay on the market even after a health emergency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results